This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinberg, A.
Right arrow Articles by Ray, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinberg, A.
Right arrow Articles by Ray, G.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, November 1998, p. 804-807, Vol. 5, No. 6
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Effect of Shipment, Storage, Anticoagulant, and Cell Separation on Lymphocyte Proliferation Assays for Human Immunodeficiency Virus-Infected Patients

Adriana Weinberg,1,* Rebecca A. Betensky,2 Li Zhang,1 and Graham Ray1

University of Colorado School of Medicine, Denver, Colorado,1 and Harvard School of Public Health, Boston, Massachusetts2

Received 12 May 1998/Returned for modification 22 June 1998/Accepted 13 August 1998

Lymphocyte proliferation assays (LPA), which can provide important information regarding the immune reconstitution of human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral therapy, frequently involve shipment of specimens to central laboratories. In this study, we examine the effect of stimulant, anticoagulant, cell separation, storage, and transportation on LPA results. LPA responses of whole blood and separated peripheral blood mononuclear cells (PBMC) to different stimulants (cytomegalovirus, varicella-zoster virus, candida and tetanus toxoid antigens, and phytohemagglutinin) were measured using fresh specimens shipped overnight and frozen specimens collected in heparin, acid citrate dextrose (ACD), and citrate cell preparation tubes (CPT) from 12 HIV-infected patients and uninfected controls. Odds ratios for positive LPA responses were significantly higher in separated PBMC than in whole blood from ACD- and heparin-anticoagulated samples obtained from HIV-infected patients and from ACD-anticoagulated samples from uninfected controls. On separated PBMC, positive responses were significantly more frequent in fresh samples compared with overnight transportation for all antigens and compared with cryopreservation for the candida and tetanus antigens. In addition, viral antigen LPA responses were better preserved in frozen PBMC compared with specimens shipped overnight. CPT tubes yielded significantly more positive LPA results for all antigens, irrespective of the HIV patient status compared with ACD, but only for the candida and tetanus antigens and only in HIV-negative controls compared with heparin. Although HIV-infected patients had a significantly lower number of positive antigen-driven LPA responses compared with uninfected controls, most of the specimen processing variables had similar effects on HIV-positive and -negative samples. We conclude that LPA should be performed on site, whenever feasible, by using separated PBMC from fresh blood samples collected in either heparin or ACD. However, if on-site testing is not available, optimal transportation conditions should be established for specific antigens.

* Corresponding author. Mailing address: University of Colorado Health Sciences Center, Campus Box C 227, 4200 East Ninth Ave., Denver, CO 80220. Phone: (303) 315-4624. Fax: (303) 315-6955. E-mail: adriana.weinberg{at}uchsc.edu.

Clinical and Diagnostic Laboratory Immunology, November 1998, p. 804-807, Vol. 5, No. 6
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Vaccari, M., Trindade, C. J., Venzon, D., Zanetti, M., Franchini, G. (2005). Vaccine-Induced CD8+ Central Memory T Cells in Protection from Simian AIDS. J. Immunol. 175: 3502-3507 [Abstract] [Full Text]  
  • Smith, J. G., Liu, X., Kaufhold, R. M., Clair, J., Caulfield, M. J. (2001). Development and Validation of a Gamma Interferon ELISPOT Assay for Quantitation of Cellular Immune Responses to Varicella-Zoster Virus. CVI 8: 871-879 [Abstract] [Full Text]  
  • Weinberg, A. (2001). In Vitro Hydroxyurea Decreases Th1 Cell-Mediated Immunity. CVI 8: 702-705 [Abstract] [Full Text]  
  • Betensky, R. A., Connick, E., Devers, J., Landay, A. L., Nokta, M., Plaeger, S., Rosenblatt, H., Schmitz, J. L., Valentine, F., Wara, D., Weinberg, A., M. Lederman, H. (2000). Shipment Impairs Lymphocyte Proliferative Responses to Microbial Antigens. CVI 7: 759-763 [Abstract] [Full Text]  
  • Kumar, P., Satchidanandam, V. (2000). Ethyleneglycol-Bis-(beta -Aminoethylether)Tetraacetate as a Blood Anticoagulant: Preservation of Antigen-Presenting Cell Function and Antigen-Specific Proliferative Response of Peripheral Blood Mononuclear Cells from Stored Blood. CVI 7: 578-583 [Abstract] [Full Text]  
  • Weinberg, A., Zhang, L., Brown, D., Erice, A., Polsky, B., Hirsch, M. S., Owens, S., Lamb, K. (2000). Viability and Functional Activity of Cryopreserved Mononuclear Cells. CVI 7: 714-716 [Abstract] [Full Text]  
  • Reimann, K. A., Chernoff, M., Wilkening, C. L., Nickerson, C. E., Landay, A. L., The ACTG Immunology Advanced Technology Laboratori, (2000). Preservation of Lymphocyte Immunophenotype and Proliferative Responses in Cryopreserved Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1-Infected Donors: Implications for Multicenter Clinical Trials. CVI 7: 352-359 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»